|
|
.
See Category: Diseases of the skin and subcutaneous tissue
See Header: Arthropathic psoriasis
ICD-10 (CM) Code and Descriptor
|
L40.53 |
Psoriatic spondylitis
|
L4053 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 50.86%
|
18.95%
|
10.09%
|
6.32%
|
4.02%
|
2.05%
|
2.46%
|
1.15%
|
1.80%
|
0.49%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for L40.53*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
80053
|
COMPREHEN METABOLIC PANEL |
272
|
272
|
|
86140
|
C-REACTIVE PROTEIN |
264
|
264
|
|
85652
|
RBC SED RATE AUTOMATED |
232
|
232
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
181
|
182
|
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
173
|
173
|
|
85027
|
COMPLETE CBC AUTOMATED |
149
|
149
|
|
96413
|
CHEMO IV INFUSION 1 HR |
121
|
121
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
104
|
104
|
|
96415
|
CHEMO IV INFUSION ADDL HR |
85
|
94
|
|
J7050
|
NORMAL SALINE SOLUTION INFUS |
83
|
87
|
|
Q5103
|
INJECTION, INFLECTRA |
66
|
4,150
|
|
J1602
|
GOLIMUMAB FOR IV USE 1MG |
65
|
8,588
|
|
82565
|
ASSAY OF CREATININE |
58
|
58
|
|
84460
|
ALANINE AMINO (ALT) (SGPT) |
50
|
50
|
|
97110
|
THERAPEUTIC EXERCISES |
50
|
95
|
|
85651
|
RBC SED RATE NONAUTOMATED |
46
|
46
|
|
96365
|
THER/PROPH/DIAG IV INF INIT |
43
|
43
|
|
84450
|
TRANSFERASE (AST) (SGOT) |
39
|
39
|
|
J0717
|
CERTOLIZUMAB PEGOL INJ 1MG |
39
|
14,800
|
|
96372
|
THER/PROPH/DIAG INJ SC/IM |
38
|
55
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
L40.53 related to the following DRG Codes:
545-547
|
